Impact of Presymptomatic Genetic Testing for Hereditary Ataxia and Neuromuscular Disorders
Open Access
- 1 June 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 61 (6) , 875-880
- https://doi.org/10.1001/archneur.61.6.875
Abstract
Background With the exception of Huntington disease, the psychological and psychosocial impact of DNA testing for neurogenetic disorders has not been well studied. Objective To evaluate the psychosocial impact of genetic testing for autosomal dominant forms of hereditary ataxia and neuromuscular disorders. Patients Fifty subjects at risk for autosomal dominant forms of spinocerebellar ataxia (n = 11), muscular dystrophy (n = 28), and hereditary neuropathy (n = 12). Design and Setting A prospective, descriptive, observational study in a university setting of individuals who underwent genetic counseling and DNA testing. Participants completed 3 questionnaires before testing and at regular intervals after testing. The questionnaire set included the Revised Impact of Event Scale, the Hospital Anxiety and Depression Scale, demographic information, and an assessment of attitudes and feelings about genetic testing. Results Thirty-nine subjects (78%) completed 6 months to 5 years of posttest follow-up. Common reasons for pursuing genetic testing were to provide an explanation for symptoms, emotional relief, and information for future planning. Thirty-four (68%) had positive and 16 (32%) had negative genetic results. In those with a positive result, 26 (76%) had nonspecific signs or symptoms of the relevant disorder. Forty-two participants (84%) felt genetic testing was beneficial. Groups with positive and negative test results coped well with results. However, 13 subjects (10 with positive and 3 with negative results) reported elevated anxiety levels, and 3 (1 with positive and 2 with negative results) expressed feelings of depression during the follow-up period. The test result was not predictive of anxiety or depression. Conclusions Most individuals find neurogenetic testing to be beneficial, regardless of the result. Anxiety or depression may persist in some persons with positive or negative test results. Testing can have a demonstrable impact on family planning and interpersonal relationships. Further studies are needed to assess the long-term impact of such testing.Keywords
This publication has 8 references indexed in Scilit:
- Impact of DNA Testing for Early-Onset Familial Alzheimer Disease and Frontotemporal DementiaArchives of Neurology, 2001
- Psychological consequences of predictive genetic testing: a systematic reviewEuropean Journal of Human Genetics, 2000
- Presymptomatic Genetic Testing with an APP Mutation in Early‐Onset Alzheimer Disease: A Descriptive Study of Sibship DynamicsJournal of Genetic Counseling, 2000
- A Worldwide Assessment of the Frequency of Suicide, Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for Huntington DiseaseAmerican Journal of Human Genetics, 1999
- Risks and Benefits of DNA Testing for Neurogenetic DisordersSeminars in Neurology, 1999
- Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.Journal of Medical Genetics, 1998
- Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: Comparing questionnaire results with in-depth interviewsAmerican Journal of Medical Genetics, 1998
- Impact of Event Scale: A Measure of Subjective StressPsychosomatic Medicine, 1979